ANGLE’s (AGL) Buy Rating Reaffirmed at Berenberg Bank

ANGLE (LON:AGL)‘s stock had its “buy” rating reiterated by analysts at Berenberg Bank in a research report issued on Wednesday, MarketBeat.com reports. They currently have a GBX 40 ($0.50) price objective on the stock. Berenberg Bank’s target price would indicate a potential upside of 174.56% from the stock’s current price.

ANGLE Trading Down 2.9 %

LON AGL opened at GBX 14.57 ($0.18) on Wednesday. ANGLE has a 52-week low of GBX 7.11 ($0.09) and a 52-week high of GBX 25.13 ($0.31). The firm has a 50-day moving average price of GBX 11.03 and a 200 day moving average price of GBX 11.17. The stock has a market capitalization of £46.99 million, a P/E ratio of -208.13 and a beta of 0.22. The company has a quick ratio of 6.18, a current ratio of 5.19 and a debt-to-equity ratio of 17.22.

About ANGLE

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.